Corbus Pharmaceuticals Reports Second Quarter Financial Results and Corporate Updates

07Aug

Corbus Pharmaceuticals Reports Second Quarter Financial Results and Corporate Updates

Portfolio News
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today reported financial results for the second quarter of 2020. The Company also provided clinical and corporate updates. Read more >>

Share this post

Related Posts

27Apr

New technology opens up new world for local man who is legally blind

A Williams county man has a whole new outlook on life, thanks to new technology. It's called eSight. The electronic glasses... read more
10May

Wasabi Technologies Out of Stealth Mode With New Cloud Storage Service Offering

Wasabi Technologies Inc., as mentioned recently, is the new company founded by serial entrepreneurs David Friend and Jeff Flowers, respectively... read more
20Jul

Archer Roose’s plan to bring canned wine to the masses

Archer Roose, a canned wine brand backed by actress Elizabeth Banks, plans to bring the nascent wine format to more... read more
03Dec

The donation of sight

North Country Association for the Visually Impaired Executive Director Amy Kretser tries on a pair of Tina Leonard’s eSight glasses... read more
02Sep

10 PORTFOLIO COMPANIES TO WATCH IN 2022

10 portfolio companies to watch in 2022 selected by Ziad Moukheiber President Boston Harbor Angels. The list is in alphabetical... read more
30Nov

Autoimmune Immunomodulator Market 2016

Autoimmune Immunomodulator Market 2016- Avaxia Biologics, Enlivex Therapeutics, Biogen Idec, AstraZeneca, Eli Lilly. A market study based on the Autoimmune Immunomodulator... read more
09May

Retail When Subscription Merchants Innovate With Plan Features

To make life easier for their customers, many businesses are adopting the subscription business model. From consumer goods and hardware... read more
04Jun

Zylö Therapeutics Closes $5.225 Million Series B Financing

Zylö Therapeutics Inc., dedicated to developing a transformational drug-delivery platform, announced that it has raised $5.225 million in its Series... read more
09Jan

Dan Feinberg: A CES 2019 Preview

The Saturday before CES begins is a transition day here in Las Vegas. The weekend sports fans and partygoers are... read more
31Jan

EcoSoul Home expands its global footprint with sustainable products

EcoSoul Home Inc., a prominent player in the eco-friendly products market, has expanded its footprint across countries such as the... read more